AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")

Clinical trial NCT07649304 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07649304
Sponsor: National Cancer Institute (NCI)
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

AIDS-Related Diffuse Large B-cell Lymphoma Diffuse Large B-Cell Lymphoma, Not Otherwise Specified High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements High Grade B-Cell Lymphoma, Not Otherwise Specified Lugano Classification Stage II Adult Non-Hodgkin Lymphoma AJCC v8 Lugano Classification Stage III Adult Non-Hodgkin Lymphoma AJCC v8 Lugano Classification Stage IV Adult Non-Hodgkin Lymphoma AJCC v8 Plasmablastic Lymphoma Primary Effusion Lymphoma

Start date: 2026-10-09
Primary completion: 2028-04-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.